Induction of matrix metalloproteinase-2 in human immunodeficiency virus- 1 glycoprotein 120 transgenic mouse brains

Neuroscience Letters

Volumn 254, Issue 2, 1998, Pages 97-100

  Marshall, D C L ^a   Wyss Coray, T ^b   Abraham, C R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquired immunodeficiency syndrome dementia; Extracellular matrix; Glycoprotein 120; Human immunodeficiency virus; Matrix metalloproteinase 2; Neurotoxicity

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; GELATINASE A;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CELL LINE, TRANSFORMED; ENZYME INDUCTION; GELATINASES; HIV ENVELOPE PROTEIN GP120; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MICE; MICE, TRANSGENIC; NEUROTOXINS; RATS; TRANSFECTION;

EID: 0032566511     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00674-0     Document Type: Article

References (19)

1. Dawson V.L., Dawson T.M., Uhl G.R., Snyder S.H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 90:1993;3256-3259.
2. Everall I., Luthert P., Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J. Neuropathol. Exp. Neurol. 51:1993;561-566.
3. Gendelman H.E., Lipton S.A., Tardieu M., Bukrinsky M.I., Nottet H.S.L.M. The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 56:1994;389-398.
4. Gottschall P.E., Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 64:1995;1513-1520.
5. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin M.A., Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
6. Giulian D., Vaca K., Noonan C.A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
7. Lim G.P., Backstrom J.R., Cullen M.J., Miller C.A., Atkinson R.D., Tokes Z.A. Matrix metalloproteinases in the neocortex and spinal cord of amytrophic lateral sclerosis patients. J. Neurochem. 67:1996;251-259.
8. Lipton S.A., Sucher N.J., Kaiser P.K., Dreyer E.B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:1991;111-118.
9. Murphy, G., Willenbrock, F., Ward, R., O'Shea, M. and Docherty, A., Studies on the structure and function of the matrix metalloproteinases and their inhibitors. In J.S. Band and A.J. Barret (Eds.), Proteolysis and Protein Turnover, Portland, London, 1993, pp. 25-32.
10. Peress N., Perillo E., Zucker S. Localization of tissue inhibitor of matrix metalloproteinase in Alzheimer's disease and normal brain. J. Neuropathol. Exp. Neurol. 54:1995;16-22.
11. Price R., Brew B., Sidtis J., Rosenblum M., Scheck A., Clevy P. The brain and SIDS: central nervous system HIV-1 infection and AIDS dementia comples. Science. 239:1988;586-592.
12. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., Sawaya R. Elevated levels of M(r) 92 000 type IV collagenase in human brain tumors. Cancer Res. 53:1993;2208-2211.
13. Ray J.M., Stetler-Stevenson W.G. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J. 14:1995;908-917.
14. Rosenberg G.A., Dencoff J.E., McGuire P.G., Liotta L.A., Stetler-Stevenson W.G. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab. Invest. 71:1994;417-422.
15. Scheider-Schaulies J., Scheider-Schaulies S., Brinkmann R., Tas P., Halbrügge M., Walter U., Holmes H.C., Meulen V. HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology. 191:1992;765-772.
16. Toggas S.M., Masliah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
17. Turck J., Pollack A.S., Lee L.K., Marti H.P., Lovett D.H. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J. Biol. Chem. 271:1996;15074-15083.
18. Watkins B.A., Dorn H.H., Kelly W.B., Armstrong R.C., Potts B.J., Michaels F., Kufta C.V., Dubois-Dalcq M. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science. 249:1990;549-553.
19. Wyss-Coray T., Masliah E., Toggas S.M., Rockenstein E.M., Brooker M.J., Lee H.S., Mucke L. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97:1996;789-798.